跳至主要内容
临床试验/NCT00583908
NCT00583908已完成不适用

Clinical and Theoretical Evaluation of Factors Affecting Soft Toric Lens Performance: Part 3

Johnson & Johnson Vision Care, Inc.1 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2007年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
14
试验地点
1
主要终点
Visual Acuity During Head Tilt

研究概览

简要总结

The purpose of this study is to determine the relative performance of a new toric soft contact lens against three toric contact lens currently available in market, specifically with orientation and visual acuity when head is tilted at 90 degrees.

详细描述

Non-dispensing single-masked (subject-masked), randomised, 1-visit controlled study, ~2 hour duration.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • be at least 18 and less than or equal to 50 years of age
  • be able and willing to adhere to the instructions set forth in the protocol.
  • have a distance spherical component between -1.00 D and -6.00D with cylinder in the range of 0.75 D to 1.75D
  • Sign the STATEMENT OF INFORMED CONSENT.
  • Have normal, healthy eyes

排除标准

  • The presence of ocular or systemic disease or need for medication which might interfere with contact lens wear.
  • Pre-existing ocular disease precluding contact lens fitting.
  • Insufficient lacrimal secretions
  • Aphakia, keratoconus or a highly irregular cornea
  • Previous eye surgery involving the anterior segment
  • Current pregnancy or lactation (to the best of the subject's knowledge).
  • Use of concurrent ocular medication
  • Active participation in another clinical study at any time during this study.-

研究组 & 干预措施

Group 1: lotrafilcon B/senofilcon A/balafilcon A/omafilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. Period 1: lotrafilcon B /period 2: senofilcon A / period 3: balafilcon A / period 4: omafilcon A

干预措施: senofilcon A (Device)

Group 1: lotrafilcon B/senofilcon A/balafilcon A/omafilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. Period 1: lotrafilcon B /period 2: senofilcon A / period 3: balafilcon A / period 4: omafilcon A

干预措施: balafilcon A toric (Device)

Group 1: lotrafilcon B/senofilcon A/balafilcon A/omafilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. Period 1: lotrafilcon B /period 2: senofilcon A / period 3: balafilcon A / period 4: omafilcon A

干预措施: lotrafilcon B toric (Device)

Group 1: lotrafilcon B/senofilcon A/balafilcon A/omafilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. Period 1: lotrafilcon B /period 2: senofilcon A / period 3: balafilcon A / period 4: omafilcon A

干预措施: omafilcon A (Device)

Group 2 lotrafilcon B/omafilcon A/senofilcon A/balafilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: lotrafilcon B / period 2: omafilcon A / period 3: senofilcon A / period 4: balafilcon A

干预措施: senofilcon A (Device)

Group 2 lotrafilcon B/omafilcon A/senofilcon A/balafilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: lotrafilcon B / period 2: omafilcon A / period 3: senofilcon A / period 4: balafilcon A

干预措施: balafilcon A toric (Device)

Group 2 lotrafilcon B/omafilcon A/senofilcon A/balafilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: lotrafilcon B / period 2: omafilcon A / period 3: senofilcon A / period 4: balafilcon A

干预措施: lotrafilcon B toric (Device)

Group 2 lotrafilcon B/omafilcon A/senofilcon A/balafilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: lotrafilcon B / period 2: omafilcon A / period 3: senofilcon A / period 4: balafilcon A

干预措施: omafilcon A (Device)

Group 3 lotrafilcon B/balafilcon A/senofilcon A/omafilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: lotrafilcon B / period 2: balafilcon A / period 3: senofilcon A / period 4: omafilcon A

干预措施: senofilcon A (Device)

Group 3 lotrafilcon B/balafilcon A/senofilcon A/omafilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: lotrafilcon B / period 2: balafilcon A / period 3: senofilcon A / period 4: omafilcon A

干预措施: balafilcon A toric (Device)

Group 3 lotrafilcon B/balafilcon A/senofilcon A/omafilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: lotrafilcon B / period 2: balafilcon A / period 3: senofilcon A / period 4: omafilcon A

干预措施: lotrafilcon B toric (Device)

Group 3 lotrafilcon B/balafilcon A/senofilcon A/omafilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: lotrafilcon B / period 2: balafilcon A / period 3: senofilcon A / period 4: omafilcon A

干预措施: omafilcon A (Device)

Group 4 senofilcon A/lotrafilcon B/omafilcon A/balafilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: senofilcon A / period 2: lotrafilcon B / period 3: omafilcon A / period 4: balafilcon A

干预措施: senofilcon A (Device)

Group 4 senofilcon A/lotrafilcon B/omafilcon A/balafilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: senofilcon A / period 2: lotrafilcon B / period 3: omafilcon A / period 4: balafilcon A

干预措施: balafilcon A toric (Device)

Group 4 senofilcon A/lotrafilcon B/omafilcon A/balafilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: senofilcon A / period 2: lotrafilcon B / period 3: omafilcon A / period 4: balafilcon A

干预措施: lotrafilcon B toric (Device)

Group 4 senofilcon A/lotrafilcon B/omafilcon A/balafilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: senofilcon A / period 2: lotrafilcon B / period 3: omafilcon A / period 4: balafilcon A

干预措施: omafilcon A (Device)

Group 5 senofilcon A/omafilcon A/balafilcon A/lotrafilcon B

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: senofilcon A / period 2: omafilcon A / period 3: balafilcon A / period 4: lotrafilcon B

干预措施: senofilcon A (Device)

Group 5 senofilcon A/omafilcon A/balafilcon A/lotrafilcon B

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: senofilcon A / period 2: omafilcon A / period 3: balafilcon A / period 4: lotrafilcon B

干预措施: balafilcon A toric (Device)

Group 5 senofilcon A/omafilcon A/balafilcon A/lotrafilcon B

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: senofilcon A / period 2: omafilcon A / period 3: balafilcon A / period 4: lotrafilcon B

干预措施: lotrafilcon B toric (Device)

Group 5 senofilcon A/omafilcon A/balafilcon A/lotrafilcon B

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: senofilcon A / period 2: omafilcon A / period 3: balafilcon A / period 4: lotrafilcon B

干预措施: omafilcon A (Device)

Group 6 senofilcon A/balafilcon A/lotrafilcon B/omafilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: senofilcon A / period 2: balafilcon A / period 3: lotrafilcon B / period 4: omafilcon A

干预措施: senofilcon A (Device)

Group 6 senofilcon A/balafilcon A/lotrafilcon B/omafilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: senofilcon A / period 2: balafilcon A / period 3: lotrafilcon B / period 4: omafilcon A

干预措施: balafilcon A toric (Device)

Group 6 senofilcon A/balafilcon A/lotrafilcon B/omafilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: senofilcon A / period 2: balafilcon A / period 3: lotrafilcon B / period 4: omafilcon A

干预措施: lotrafilcon B toric (Device)

Group 6 senofilcon A/balafilcon A/lotrafilcon B/omafilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: senofilcon A / period 2: balafilcon A / period 3: lotrafilcon B / period 4: omafilcon A

干预措施: omafilcon A (Device)

Group 7 omafilcon B/lotrafilcon B/senofilcon A/balafilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: omafilcon A / period 2: lotrafilcon B / period 3: senofilcon A / period 4: balafilcon A

干预措施: senofilcon A (Device)

Group 7 omafilcon B/lotrafilcon B/senofilcon A/balafilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: omafilcon A / period 2: lotrafilcon B / period 3: senofilcon A / period 4: balafilcon A

干预措施: balafilcon A toric (Device)

Group 7 omafilcon B/lotrafilcon B/senofilcon A/balafilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: omafilcon A / period 2: lotrafilcon B / period 3: senofilcon A / period 4: balafilcon A

干预措施: lotrafilcon B toric (Device)

Group 7 omafilcon B/lotrafilcon B/senofilcon A/balafilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: omafilcon A / period 2: lotrafilcon B / period 3: senofilcon A / period 4: balafilcon A

干预措施: omafilcon A (Device)

Group 8 balafilcon A/lotrafilcon B/senofilcon A/omafilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: lotrafilcon B / period 3: senofilcon A / period 4: omafilcon A

干预措施: senofilcon A (Device)

Group 8 balafilcon A/lotrafilcon B/senofilcon A/omafilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: lotrafilcon B / period 3: senofilcon A / period 4: omafilcon A

干预措施: balafilcon A toric (Device)

Group 8 balafilcon A/lotrafilcon B/senofilcon A/omafilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: lotrafilcon B / period 3: senofilcon A / period 4: omafilcon A

干预措施: lotrafilcon B toric (Device)

Group 8 balafilcon A/lotrafilcon B/senofilcon A/omafilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: lotrafilcon B / period 3: senofilcon A / period 4: omafilcon A

干预措施: omafilcon A (Device)

Group 9 balafilcon A/lotrafilcon B/omafilcon A/senofilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: lotrafilcon B / period 3: omafilcon A / period 4: senofilcon A

干预措施: senofilcon A (Device)

Group 9 balafilcon A/lotrafilcon B/omafilcon A/senofilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: lotrafilcon B / period 3: omafilcon A / period 4: senofilcon A

干预措施: balafilcon A toric (Device)

Group 9 balafilcon A/lotrafilcon B/omafilcon A/senofilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: lotrafilcon B / period 3: omafilcon A / period 4: senofilcon A

干预措施: lotrafilcon B toric (Device)

Group 9 balafilcon A/lotrafilcon B/omafilcon A/senofilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: lotrafilcon B / period 3: omafilcon A / period 4: senofilcon A

干预措施: omafilcon A (Device)

Group 10 balafilcon A/senofilcon A/lotrafilcon B/omafilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: senofilcon A / period 3: lotrafilcon B / period 4: omafilcon A

干预措施: senofilcon A (Device)

Group 10 balafilcon A/senofilcon A/lotrafilcon B/omafilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: senofilcon A / period 3: lotrafilcon B / period 4: omafilcon A

干预措施: balafilcon A toric (Device)

Group 10 balafilcon A/senofilcon A/lotrafilcon B/omafilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: senofilcon A / period 3: lotrafilcon B / period 4: omafilcon A

干预措施: lotrafilcon B toric (Device)

Group 10 balafilcon A/senofilcon A/lotrafilcon B/omafilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: senofilcon A / period 3: lotrafilcon B / period 4: omafilcon A

干预措施: omafilcon A (Device)

Group 11 balafilcon A/senofilcon A/omafilcon A//lotrafilcon B

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: senofilcon A / period 3: omafilcon A / period 4: lotrafilcon B

干预措施: senofilcon A (Device)

Group 11 balafilcon A/senofilcon A/omafilcon A//lotrafilcon B

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: senofilcon A / period 3: omafilcon A / period 4: lotrafilcon B

干预措施: balafilcon A toric (Device)

Group 11 balafilcon A/senofilcon A/omafilcon A//lotrafilcon B

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: senofilcon A / period 3: omafilcon A / period 4: lotrafilcon B

干预措施: lotrafilcon B toric (Device)

Group 11 balafilcon A/senofilcon A/omafilcon A//lotrafilcon B

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: senofilcon A / period 3: omafilcon A / period 4: lotrafilcon B

干预措施: omafilcon A (Device)

Group 12 balafilcon A/omafilcon A/lotrafilcon B/senofilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: omafilcon A / period 3: lotrafilcon B / period 4: senofilcon A

干预措施: senofilcon A (Device)

Group 12 balafilcon A/omafilcon A/lotrafilcon B/senofilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: omafilcon A / period 3: lotrafilcon B / period 4: senofilcon A

干预措施: balafilcon A toric (Device)

Group 12 balafilcon A/omafilcon A/lotrafilcon B/senofilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: omafilcon A / period 3: lotrafilcon B / period 4: senofilcon A

干预措施: lotrafilcon B toric (Device)

Group 12 balafilcon A/omafilcon A/lotrafilcon B/senofilcon A

Active Comparator

One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: omafilcon A / period 3: lotrafilcon B / period 4: senofilcon A

干预措施: omafilcon A (Device)

结局指标

主要结局

Visual Acuity During Head Tilt

时间窗: after each of the four lens insertions

logarithm of the minimum angle of resolution (logMar) ideal is 0.0 and represents 20/20 Snellen acuity. logMar values \> 0.00 indicate vision poorer than the ideal and values \<0.00 indicate vision greater than the ideal.

Lens Orientation During Head Tilt.

时间窗: after fit of each of the four lens insertions

Degree of lens rotation on the eye with the head tilted.

次要结局

  • Degree of Lens Rotation in Temporal Gaze.(After each of the four lens insertions)
  • Degree of Lens Rotation in Superior Gaze.(After each of the four lens insertions)
  • Degree of Lens Rotation in Superior-temporal Gaze.(After each of 4 lens insertions.,)
  • Degree of Lens Rotation in Inferior Gaze.(After each of the four lens insertions)
  • Degree of Lens Rotation Inferior-temporal Gaze.(After each of the four lens insertions)
  • Degree of Lens Rotation in Superior-nasal Gaze.(After each of the four lens insertions)
  • Degree of Lens Rotation in Nasal Gaze.(After each of the four lens insertions)
  • Degree of Lens Rotation in Inferior-nasal Gaze.(After each of the four lens insertions)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验